top of page
logo

Advancing Human Health Through Innovative Biologics Development

Our strategic focus centers on creating novel biologics to address unmet medical needs. Through rigorous scientific exploration and an advanced engineering platform, we develop molecular treatments designed to improve patient outcomes. We are committed to translating complex biological insights into transformative therapies.

Discovery

PC-102: Novel Protein Therapy

Biologic Innovation: Targeting Intracellular Health Pathways

Pre-clinical

PC-204: Therapeutic Biologic

Health Sciences: Enhancing Cellular Response Mechanisms

Phase I

PC-301: Advanced Biologic

Targeted Therapy: Precision Delivery for Human Health

Phase II

PC-507: Specialized Biologic

Therapeutic Core: Resolving Complex Disease Pathologies

Current Clinical Pipeline

Showcasing our primary research assets and therapeutic candidates currently in development to address critical global health challenges.

bottom of page